Share the Science with Morey Kraus: Future of Perinatal Stem Cells from Umbilical Cord Tissue9/13/2016
 Share the Science with Morey Kraus: Future of Perinatal Stem Cells from Umbilical Cord Tissue Share the Science with Morey Kraus: Perinatal Stem Cells from Umbilical Cord Tissue and Their Potential Use in Newborns with Hypoxic Ischemic Injuries Morey Kraus is the Chief Scientific Officer of the Diagnostics division of PerkinElmer, Inc. where he oversees scientific affairs for the maternal fetal health business. In this webinar, Mr. Kraus speaks on the potential use of perinatal stem cells from umbilical cord tissue and their potential use in newborns with hypoxic ischemic injuries. Exciting research is happening using these cells and Mr. Kraus will share his valuable insight on the subject. Kraus was the founder, chairman and Chief Executive Officer of t. Breeders, a cellular therapy company, later called ViaCell, focused on stem cell expansion technologies for clinical transplantation. ViaCell (home of Viacord) was acquired by PerkinElmer in 2007. Mr. Kraus was a Ph.D. candidate at Worcester Polytechnic Institute in an interdisciplinary Bioprocess Engineering Program combining Chemical Engineering and Biotechnology. He holds a B.A. in comparative religion from American University in Washington, D.C.. Share the Science with Mr. Morey Kraus “Perinatal Stem Cells from Umbilical Cord Tissue and Their Potential Use in Newborns with Hypoxic Ischemic Injuries” Thursday, September 22nd, 11:00-12:00 a.m. Central Time Free webinar. Open to the public. VIEW THE RECORDED WEBINAR This webinar provides an understanding of what perinatal stem cells are and are not as well as methods of isolation, characterization, and storage. This includes the characterization of different sources and types of stem cells available in the umbilical vein and cord itself, such as hematopoietic, mesenchymal, and mixed heterogeneous stem cells. Methods of isolation and storage, including enzyme digestion and whole tissue cryopreservation, also will be discussed. Regenerative medicine applications of perinatal stem cells from cord tissue may include autoimmune disorders, sports injuries, and organ damage. The proposition of using perinatal stem cells alone or in combination with cord blood in autologous or related allogeneic clinical studies is likely to be dependent on their availability for newborns and children with acute medical challenges involving the lung, gut, and brain. Applications in lung disorders may include bronchopulmonary dysplasia, asthma, and severe allergies. Gut disorders may include necrotizing enterocolitis and Crohn’s; and brain disorders may include hypoxic ischemic encephalopathy and cerebral palsy. Kraus also briefly discusses matching principles, which may increase the utility of collections for haploidentical family members and the potential of regenerative medicine applications of perinatal stem cells from cord tissue. A review of data from several animal models distinguishing the biological potential of these stem cells in animal models, including hypoxic ischemic injury is included. ***** Save the Cord had the pleasure of speaking with Morey Kraus earlier this year at the Perinatal Stem Cell Conference. Watch this short videoand get a preview of what he will be presenting on Share the Science this month. A special thank you to Morey Kraus and our friends at Mediware Information Systems who have helped make this webinar possible through their generous support. Are you enjoying our Share the Science series? Thank you for joining us each time for a new and exciting discussion with a leading cord blood expert. We never charge a fee for our programs and we want to keep it that way. At Save the Cord Foundation, we are serious about cord blood education. Help us to keep programs like Share the Science going strong and keep the cord blood industry growing strong, together. Make a tax-deductible donation today! Thank you. Comments are closed.
|
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
March 2025
Categories |
RSS Feed
